| [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ... The Lancet Oncology 19 (6), 825-833, 2018 | 1039 | 2018 |
| Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy WN Rahman, N Bishara, T Ackerly, CF He, P Jackson, C Wong, ... Nanomedicine in Cancer, 737-752, 2017 | 489 | 2017 |
| Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ... Journal of Nuclear Medicine 60 (4), 517-523, 2019 | 404 | 2019 |
| Long-term follow-up and outcomes of retreatment in an expanded 50-patient single-center phase II prospective trial of 177Lu-PSMA-617 theranostics in metastatic castration … J Violet, S Sandhu, A Iravani, J Ferdinandus, SP Thang, G Kong, ... Journal of Nuclear Medicine 61 (6), 857-865, 2020 | 268 | 2020 |
| Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents PA Jackson, WNWA Rahman, CJ Wong, T Ackerly, M Geso European journal of radiology 75 (1), 104-109, 2010 | 148 | 2010 |
| Fast and low-GPU-memory abdomen CT organ segmentation: the flare challenge J Ma, Y Zhang, S Gu, X An, Z Wang, C Ge, C Wang, F Zhang, Y Wang, ... Medical Image Analysis 82, 102616, 2022 | 137 | 2022 |
| 64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor … RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman, DA Pattison, ... Journal of Nuclear Medicine 60 (6), 777-785, 2019 | 122 | 2019 |
| Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy P Jackson, N Hardcastle, N Dawe, T Kron, MS Hofman, RJ Hicks Frontiers in oncology 8, 215, 2018 | 122 | 2018 |
| Radiation dosimetry in 177Lu-PSMA-617 therapy using a single posttreatment SPECT/CT scan: a novel methodology to generate time-and tissue-specific dose factors PA Jackson, MS Hofman, RJ Hicks, M Scalzo, J Violet Journal of Nuclear Medicine 61 (7), 1030-1036, 2020 | 113 | 2020 |
| Mitogen-activated protein kinase pathway inhibition for redifferentiation of radioiodine refractory differentiated thyroid cancer: an evolving protocol A Iravani, B Solomon, DA Pattison, P Jackson, A Ravi Kumar, G Kong, ... Thyroid 29 (11), 1634-1645, 2019 | 100 | 2019 |
| An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging PA Jackson, JM Beauregard, MS Hofman, T Kron, A Hogg, RJ Hicks Medical physics 40 (11), 112503, 2013 | 94 | 2013 |
| Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship S Siva, P Jackson, T Kron, M Bressel, E Lau, M Hofman, M Shaw, ... Radiotherapy and Oncology 118 (3), 540-546, 2016 | 79 | 2016 |
| Cold kit for prostate-specific membrane antigen (PSMA) PET imaging: phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer MS Hofman, P Eu, P Jackson, E Hong, D Binns, A Iravani, D Murphy, ... Journal of Nuclear Medicine 59 (4), 625-631, 2018 | 66 | 2018 |
| Evaluation of the effects of gold nanoparticle shape and size on contrast enhancement in radiological imaging P Jackson, S Periasamy, V Bansal, M Geso Australasian Physical & Engineering Sciences in Medicine 34, 243-249, 2011 | 62 | 2011 |
| Peptide receptor radionuclide therapy with 67Cu-CuSarTATE is highly efficacious against a somatostatin-positive neuroendocrine tumor model C Cullinane, CM Jeffery, PD Roselt, EM van Dam, S Jackson, K Kuan, ... Journal of Nuclear Medicine 61 (12), 1800-1805, 2020 | 56 | 2020 |
| Clinical trial protocol for LuTectomy: a single-arm study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 prior to prostatectomy N Dhiantravan, J Violet, R Eapen, O Alghazo, M Scalzo, P Jackson, ... European urology focus 7 (2), 234-237, 2021 | 45 | 2021 |
| Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion R Kashyap, P Jackson, MS Hofman, P Eu, JM Beauregard, D Zannino, ... European journal of nuclear medicine and molecular imaging 40, 1853-1860, 2013 | 38 | 2013 |
| A deep learning model to automate skeletal muscle area measurement on computed tomography images KC Amarasinghe, J Lopes, J Beraldo, N Kiss, N Bucknell, S Everitt, ... Frontiers in Oncology 11, 580806, 2021 | 34 | 2021 |
| timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99mTc-DMSA SPECT/CT P Jackson, F Foroudi, D Pham, MS Hofman, N Hardcastle, J Callahan, ... Radiation Oncology 9, 1-4, 2014 | 34 | 2014 |
| Administering [177Lu] Lu-PSMA-617 prior to radical prostatectomy in men with high-risk localised prostate cancer (LuTectomy): a single-centre, single-arm, phase 1/2 study RS Eapen, JP Buteau, P Jackson, C Mitchell, SF Oon, O Alghazo, ... European Urology 85 (3), 217-226, 2024 | 33 | 2024 |
